Evidence map›Paper›PMID 27630019›Full record

ArticleAutophagy2016

Characterization of Atg38 and NRBF2, a fifth subunit of the autophagic Vps34/PIK3C3 complex.

Yohei Ohashi, Nicolas Soler, Miguel García Ortegón, Lufei Zhang, Marie L Kirsten, Olga Perisic, Glenn R Masson, John E Burke, Arjen J Jakobi, Apostolos A Apostolakis and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Autophagy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of Sigmar1 in Autophagy Regulation and Disease Therapy.International journal of molecular sciences · 2026
    Review
  4. The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  5. Article
  6. The human autophagy-initiating complexes ULK1C and PI3KC3-C1.The Journal of biological chemistry · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Yohei Ohashia MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Nicolas Solera MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Miguel García Ortegóna MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Lufei Zhanga MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Marie L Kirstenb European Molecular Biology Laboratory , Structural and Computational Biology Unit , Heidelberg , Germany.
Olga Perisica MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Glenn R Massona MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
John E Burkeb European Molecular Biology Laboratory , Structural and Computational Biology Unit , Heidelberg , Germany.
Arjen J Jakobib European Molecular Biology Laboratory , Structural and Computational Biology Unit , Heidelberg , Germany.
Apostolos A Apostolakisa MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Christopher M Johnsona MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Maki Ohashia MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
Nicholas T Ktistakisd The Babraham Institute , Cambridge , UK.
Carsten Sachseb European Molecular Biology Laboratory , Structural and Computational Biology Unit , Heidelberg , Germany.
Roger L Williamsa MRC Laboratory of Molecular Biology , Cambridge , United Kingdom.
MRC Laboratory of Molecular Biology · GBEuropean Molecular Biology Laboratory · DEBabraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K019155/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0413British Heart Foundation PG11/109/29247Medical Research Council MC_U105184308
6 · The paper itself

Abstract

The phosphatidylinositol 3-kinase Vps34 is part of several protein complexes. The structural organization of heterotetrameric complexes is starting to emerge, but little is known about organization of additional accessory subunits that interact with these assemblies. Combining hydrogen-deuterium exchange mass spectrometry (HDX-MS), X-ray crystallography and electron microscopy (EM), we have characterized Atg38 and its human ortholog NRBF2, accessory components of complex I consisting of Vps15-Vps34-Vps30/Atg6-Atg14 (yeast) and PIK3R4/VPS15-PIK3C3/VPS34-BECN1/Beclin 1-ATG14 (human). HDX-MS shows that Atg38 binds the Vps30-Atg14 subcomplex of complex I, using mainly its N-terminal MIT domain and bridges the coiled-coil I regions of Atg14 and Vps30 in the base of complex I. The Atg38 C-terminal domain is important for localization to the phagophore assembly site (PAS) and homodimerization. Our 2.2 Å resolution crystal structure of the Atg38 C-terminal homodimerization domain shows 2 segments of α-helices assembling into a mushroom-like asymmetric homodimer with a 4-helix cap and a parallel coiled-coil stalk. One Atg38 homodimer engages a single complex I. This is in sharp contrast to human NRBF2, which also forms a homodimer, but this homodimer can bridge 2 complex I assemblies.

Indexed as

AutophagyAutophagy-Related ProteinsClass III Phosphatidylinositol 3-KinasesCrystallography, X-RayDeuterium Exchange MeasurementHEK293 CellsHumansMass SpectrometryMultiprotein ComplexesProtein BindingProtein DomainsProtein Interaction MappingProtein MultimerizationProtein SubunitsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAtg38 protein, S cerevisiaeAutophagy-Related ProteinsClass III Phosphatidylinositol 3-KinasesMultiprotein ComplexesNRBF2 protein, humanProtein SubunitsSaccharomyces cerevisiae ProteinsTrans-ActivatorsAtg14Atg38Beclin 1complex Icrystal structureEM structureNRBF2Vps15Vps30Vps34

Identifiers

PMID27630019
PMCPMC5103362
OpenAlexW2519177997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.